Novel Concepts in the Genesis of Hypertension: Role of LOX-1

被引:0
|
作者
Ping Luo
Meiling Yan
Edward D. Frohlich
Jawahar L. Mehta
Changping Hu
机构
[1] Central South University,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ochsner Clinic Foundation,Division of Cardiovascular Medicine
[3] University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System,undefined
来源
Cardiovascular Drugs and Therapy | 2011年 / 25卷
关键词
Hypertension; Lectin-like oxidized low-density lipoprotein receptor-1; Oxidative stress; Angiotensin II;
D O I
暂无
中图分类号
学科分类号
摘要
Hypertension is a common disease and a potent risk factor for cardiovascular disease. Tremendous strides have been made in understanding its genesis in the last 2 decades. Hypertension is often clustered with other cardiovascular risk factors, such as dyslipidemia and diabetes. The state of hypertension is often associated with increased vascular oxidative stress. Oxidative stress promotes proliferation and hypertrophy of vascular smooth muscle cell and collagen deposition, leading to thickening of the vascular media and narrowing of the vascular lumen. Oxidative stress also injures endothelium, impairs endothelium-dependent vascular relaxation and increases vascular contractile activity. Further, oxidative stress also oxidizes LDL-cholesterol. It has been shown that oxidized low-density lipoprotein (ox-LDL) activates renin-angiotensin system (RAS) and angiotensin II via its type 1 receptor activates ox-LDL receptor LOX-1. This mutually facilitative cross-talk between ox-LDL and RAS may be an important component in the development of hypertension. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a receptor for ox-LDL. This review summarizes the role of LOX-1 in the pathogenesis of hypertension.
引用
收藏
页码:441 / 449
页数:8
相关论文
共 50 条
  • [41] Elevation of circulating LOX-1 ligand levels in Zucker obese and diabetic rats
    Wakabayashi, Ichiro
    Shimomura, Tomoko
    Nakanishi, Mamoru
    Uchida, Kagehiro
    OBESITY RESEARCH & CLINICAL PRACTICE, 2015, 9 (01) : 26 - 30
  • [42] LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats
    Zhu, Tian-Tian
    Zhang, Wei-Fang
    Luo, Ping
    Qian, Zhao-Xin
    Li, Feng
    Zhang, Zheng
    Hu, Chang-Ping
    LIFE SCIENCES, 2017, 174 : 35 - 42
  • [43] Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uraemia?
    Tepel, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (08) : 1439 - 1442
  • [44] LOX-1 Deletion Limits Cardiac Angiogenesis in Mice Given Angiotensin II
    Wang, Xianwei
    Khaidakov, Magomed
    Guo, Zhikun
    Ding, Zufeng
    He, Quanzhong
    Mehta, Jawahar L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (05) : 441 - 446
  • [45] LOX-1 Deletion Limits Cardiac Angiogenesis in Mice Given Angiotensin II
    Xianwei Wang
    Magomed Khaidakov
    Zhikun Guo
    Zufeng Ding
    Quanzhong He
    Jawahar L Mehta
    Cardiovascular Drugs and Therapy, 2014, 28 : 441 - 446
  • [46] LOX-1 Knockout Mice Preserve Against Doxorubicin-Induced Cardiomyopathy
    Yokoyama, Chiharu
    Aoyama, Takuma
    Shiraki, Takeru
    Hayakawa, Yuka
    Takeyama, Toshiaki
    Nishigaki, Kazuhiko
    Fujiwara, Takako
    Fujiwara, Hisayoshi
    Sawamura, Tatsuya
    Minatoguchi, Shinya
    CIRCULATION, 2011, 124 (21)
  • [47] Identification of peptides that target the endothelial cell-specific LOX-1 receptor
    White, SJ
    Nicklin, SA
    Sawamura, T
    Baker, AH
    HYPERTENSION, 2001, 37 (02) : 449 - 455
  • [48] Inflammation in the genesis of hypertension and its complicationsthe role of angiotensin II
    Li, Jun
    Doerffel, Yvonne
    Hocher, Berthold
    Unger, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3107 - 3109
  • [49] Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
    Lubrano, Valter
    Balzan, Silvana
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 464 (1-2) : 143 - 152
  • [50] LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions
    Lubrano, Valter
    Balzan, Silvana
    Papa, Angela
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (09) : 2245 - 2254